Literature DB >> 27550341

Impact of BNP level and peak VO2 on future heart failure events: comparison between sinus rhythm and atrial fibrillation.

Yuko Kato1, Shinya Suzuki2, Tokuhisa Uejima2, Hiroaki Semba2, Hiroto Kano2, Shunsuke Matsuno2, Hideaki Takai3, Takayuki Otsuka2, Yuji Oikawa2, Kazuyuki Nagashima2, Hajime Kirigaya2, Koichi Sagara2, Takashi Kunihara3, Junji Yajima2, Hitoshi Sawada2, Tadanori Aizawa2, Takeshi Yamashita2.   

Abstract

This study aimed to examine the discrete impacts of peak oxygen consumption (VO2) and brain natriuretic peptide (BNP) levels on future heart failure (HF) events in sinus rhythm (SR) and atrial fibrillation (AF). A total of 1447 patients who underwent symptom-limited cardiopulmonary exercise testing and whose BNP values were determined simultaneously were analysed (SR, N = 1151 and AF, N = 296). HF events were defined as HF hospitalization or HF death. Over a mean follow-up period of 1472 days, 140 HF events were observed. A high BNP value (dichotomized by median value) was independently associated with HF events in SR (HR 8.08; 95 % CI 4.02-16.26; p < 0.0001), but not in AF patients (HR 1.97; 95 % CI 0.91-4.28; p = 0.087) with a significant interaction between the rhythms. By contrast, low-peak VO2 was independently associated with HF events in both rhythms (AF; HR 5.81; 95 % CI 1.75-19.30; p = 0.004, SR; HR 2.04; 95 % CI 1.19-3.49; p = 0.009), with a marginal interaction between them. In bivariate Cox models, low-peak VO2 had much stronger predictive power for HF events than high-BNP in AF, whereas high-BNP was more powerful than low-peak VO2 in SR. The prognostic value of BNP and peak VO2 for future HF events seemed to be different between SR and AF.

Entities:  

Keywords:  Atrial fibrillation; Brain natriuretic peptide; Peak VO2; Sinus rhythm

Mesh:

Substances:

Year:  2016        PMID: 27550341     DOI: 10.1007/s00380-016-0887-x

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  22 in total

1.  NT-proBNP values in elderly heart failure patients with atrial fibrillation and diabetes.

Authors:  Adela Viviana Sitar Taut; Dana Pop; Dumitru Tudor Zdrenghea
Journal:  J Diabetes Complications       Date:  2015-08-20       Impact factor: 2.852

2.  Prognostic significance of exercise capacity and resting heart rate: Comparison between atrial fibrillation and sinus rhythm.

Authors:  Yuko Kato; Shinya Suzuki; Hiroto Kano; Hioaki Semba; Shunsuke Matsuno; Hideaki Takai; Takayuki Otsuka; Tokuhisa Uejima; Yuji Oikawa; Kazuyuki Nagashima; Hajime Kirigaya; Koichi Sagara; Takashi Kunihara; Junji Yajima; Hitoshi Sawada; Tadanori Aizawa; Takeshi Yamashita
Journal:  Int J Cardiol       Date:  2015-10-30       Impact factor: 4.164

3.  Deceptive meaning of oxygen uptake measured at the anaerobic threshold in patients with systolic heart failure and atrial fibrillation.

Authors:  Damiano Magrì; Piergiuseppe Agostoni; Ugo Corrà; Claudio Passino; Domenico Scrutinio; Pasquale Perrone-Filardi; Michele Correale; Gaia Cattadori; Marco Metra; Davide Girola; Massimo F Piepoli; AnnaMaria Iorio; Michele Emdin; Rosa Raimondo; Federica Re; Mariantonietta Cicoira; Romualdo Belardinelli; Marco Guazzi; Giuseppe Limongelli; Francesco Clemenza; Gianfranco Parati; Maria Frigerio; Matteo Casenghi; Angela B Scardovi; Alessandro Ferraironi; Andrea Di Lenarda; Maurizio Bussotti; Anna Apostolo; Stefania Paolillo; Rocco La Gioia; Paola Gargiulo; Pietro Palermo; Chiara Minà; Stefania Farina; Elisa Battaia; Antonello Maruotti; Giuseppe Pacileo; Mauro Contini; Fabrizio Oliva; Roberto Ricci; Gianfranco Sinagra
Journal:  Eur J Prev Cardiol       Date:  2014-09-26       Impact factor: 7.804

4.  A new scoring system for evaluating the risk of heart failure events in Japanese patients with atrial fibrillation.

Authors:  Shinya Suzuki; Koichi Sagara; Takayuki Otsuka; Shunsuke Matsuno; Ryuichi Funada; Tokuhisa Uejima; Yuji Oikawa; Junji Yajima; Akira Koike; Kazuyuki Nagashima; Hajime Kirigaya; Hitoshi Sawada; Tadanori Aizawa; Takeshi Yamashita
Journal:  Am J Cardiol       Date:  2012-05-22       Impact factor: 2.778

5.  Histological substrate of atrial biopsies in patients with lone atrial fibrillation.

Authors:  A Frustaci; C Chimenti; F Bellocci; E Morgante; M A Russo; A Maseri
Journal:  Circulation       Date:  1997-08-19       Impact factor: 29.690

6.  Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Ramachandran S Vasan; Eric P Leip; Philip A Wolf; Ralph B D'Agostino; Joanne M Murabito; William B Kannel; Emelia J Benjamin
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

7.  Brain natriuretic peptide levels fall rapidly after cardioversion of atrial fibrillation to sinus rhythm.

Authors:  Craig S Vinch; Jason Rashkin; Giridhar Logsetty; Dennis A Tighe; Jeffrey C Hill; Theo E Meyer; Lawrence S Rosenthal; Gerard P Aurigemma
Journal:  Cardiology       Date:  2004-09-22       Impact factor: 1.869

8.  B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure.

Authors:  Pascal de Groote; Joël Dagorn; Benoit Soudan; Nicolas Lamblin; Eugene McFadden; Christophe Bauters
Journal:  J Am Coll Cardiol       Date:  2004-05-05       Impact factor: 24.094

9.  N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).

Authors:  Ziad Hijazi; Lars Wallentin; Agneta Siegbahn; Ulrika Andersson; Christina Christersson; Justin Ezekowitz; Bernard J Gersh; Michael Hanna; Stefan Hohnloser; John Horowitz; Kurt Huber; Elaine M Hylek; Renato D Lopes; John J V McMurray; Christopher B Granger
Journal:  J Am Coll Cardiol       Date:  2013-04-03       Impact factor: 24.094

10.  Plasma B-type natriuretic peptide as a predictor of cardiovascular events in subjects with atrial fibrillation: a community-based study.

Authors:  Motoyuki Nakamura; Yorihiko Koeda; Fumitaka Tanaka; Toshiyuki Onoda; Kazuyoshi Itai; Masaki Ohsawa; Kozo Tanno; Kiyomi Sakata; Shinich Omama; Yasuhiro Ishibashi; Shinji Makita; Mutsuko Ohta; Kuniaki Ogasawara; Takashi Komatsu; Akira Okayama
Journal:  PLoS One       Date:  2013-12-02       Impact factor: 3.240

View more
  4 in total

1.  Prognostic value of selected echocardiographic, impedance cardiographic, and hemodynamic parameters determined during right heart catheterization in patients qualified for heart transplantation.

Authors:  Wojciech Gilewski; Jarosław Pietrzak; Joanna Banach; Robert Bujak; Jan Błażejewski; Danuta Karasek; Łukasz Wołowiec; Władysław Sinkiewicz
Journal:  Heart Vessels       Date:  2017-09-22       Impact factor: 2.037

2.  Evaluation of end-tidal CO2 pressure at the anaerobic threshold for detecting and assessing pulmonary hypertension.

Authors:  Akifumi Higashi; Yoshihiro Dohi; Sayuri Yamabe; Hiroki Kinoshita; Yoshiharu Sada; Toshiro Kitagawa; Takayuki Hidaka; Satoshi Kurisu; Hideya Yamamoto; Yuji Yasunobu; Yasuki Kihara
Journal:  Heart Vessels       Date:  2017-05-30       Impact factor: 2.037

3.  Predictors of improvements in exercise capacity during cardiac rehabilitation in the recovery phase after coronary artery bypass graft surgery versus acute myocardial infarction.

Authors:  Yuji Suzuki; Kenichi Ito; Kazuya Yamamoto; Noriyuki Fukui; Hidetoshi Yanagi; Kazufumi Kitagaki; Harumi Konishi; Tetsuo Arakawa; Michio Nakanishi; Yoichi Goto
Journal:  Heart Vessels       Date:  2017-11-08       Impact factor: 2.037

4.  Effect of exercise therapy on established and emerging circulating biomarkers in patients with heart failure: a systematic review and meta-analysis.

Authors:  Melissa J Pearson; Nicola King; Neil A Smart
Journal:  Open Heart       Date:  2018-07-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.